- Main
Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
- Bhojwani, Deepa;
- Sposto, Richard;
- Shah, Nirali N;
- Rodriguez, Vilmarie;
- Yuan, Constance;
- Stetler-Stevenson, Maryalice;
- O’Brien, Maureen M;
- McNeer, Jennifer L;
- Quereshi, Amrana;
- Cabannes, Aurelie;
- Schlegel, Paul;
- Rossig, Claudia;
- Dalla-Pozza, Luciano;
- August, Keith;
- Alexander, Sarah;
- Bourquin, Jean-Pierre;
- Zwaan, Michel;
- Raetz, Elizabeth A;
- Loh, Mignon L;
- Rheingold, Susan R
- et al.
Published Web Location
https://doi.org/10.1038/s41375-019-0426-8Abstract
We thank the research coordinators and following physicians at pediatric cancer centers for contributing data to this project: Prashant Hiwarkar and Jayashree Motwani, Birmingham Women's and Children's Hospital, UK; Kelly Malone, Children's Hospital of Colorado, USA; Mylene Bassal, Children's Hospital of Eastern Ontario, Canada; Yoav Messinger and Joanna Perkins, Children's Hospital of Minnesota, USA; Van Huynh, Children's Hospital of Orange County, USA; Richard Ho, Children's Hospital at Vanderbilt, USA; Joanne Chuah and Jessa Morales, Children's Hospital at Westmead, Australia; Donald Wells, Dell Children's Hospital, USA; Nicolas Boissel, Hospital Saint-Louis, France; Tannie Huang, Kaiser Permanente, USA; Stacey Marjerrison, McMaster Children's Hospital, Canada; William Carroll and Joanna Pierro, New York University Langone Medical Center, USA; Ajay Vora, Sheffield Children's Hospital, UK; Donna Lancaster, The Royal Marsden Hospital, UK; Lucie Šrámková, University Hospital Motol, Czech Republic; Chatchawin Assanasen, University of Texas Health Science Center, San Antonio, USA; Rupert Handgretinger, University of Tübingen, Germany.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-